Morning Overview on MSN
A targeted drug won approval for a hard-to-treat form of advanced prostate cancer
Men diagnosed with metastatic hormone-sensitive prostate cancer who carry a specific tumor deficiency now have a targeted ...
NeoGenomics launched PTEN IHC CDx, the first IHC companion diagnostic test approved by the U.S. FDA for patients with ...
A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...
Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of ...
Bay Area-raised host Ericka Cruz Guevarra brings you context and analysis to make sense of the news. Episodes drop Monday, Wednesday, and Friday. Emma’s Must-Sees See TV Programming Manager Emma ...
If you’re dealing with advanced prostate cancer, the thought of surgery might feel like a lot to take in — and that’s completely understandable. For many men facing an advanced diagnosis, surgery will ...
The study is aimed at advancing personalized cancer treatment by exploring a personalized approach to radioligand therapy.
Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called metastatic or stage 4 prostate cancer. While most advanced prostate cancer is ...
From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...
The vast majority of people diagnosed with prostate cancer can expect to live long, full lives thanks to improved screening that catches the disease in its early and most treatable stages. But ...
CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ...
Thousands of men in England who have prostate cancer will be offered high-powered precision radiotherapy that will slash the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results